A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/48 (2006.01) A61K 31/522 (2006.01) A61K 47/48 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2671209
Provided are methods for treating an adenosine deaminase-mediated pulmonary disease such as asthma, pulmonary fibrosis, cystic fibrosis and chronic obstructive pulmonary disease in a mammal in need thereof, by administering an effective amount of a polymer-conjugated adenosine deaminase.
L'invention concerne des procédés permettant le traitement d'une maladie pulmonaire véhiculée par l'adénosine déaminase telle que l'asthme, la fibrose pulmonaire, la mucoviscidose, et la broncho-pneumopathie chronique obstructive chez un mammifère en besoin de celui-ci, par l'administration d'une quantité efficace d'une adénosine déaminase conjuguée à un polymère.
Blackburn Michael R.
Horak Ivan
Kellems Rodney E.
Sapra Puja
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Board Of Regents Of The University Of Texas System
Defiante Farmaceutica S.a.
Enzon Pharmaceuticals Inc.
LandOfFree
Use of adenosine deaminase for treating pulmonary disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of adenosine deaminase for treating pulmonary disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adenosine deaminase for treating pulmonary disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1619179